GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenfern Industries Ltd (NZSE:GFI) » Definitions » Additional Paid-In Capital

Greenfern Industries (NZSE:GFI) Additional Paid-In Capital : NZ$0.00 Mil(As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Greenfern Industries Additional Paid-In Capital?



Greenfern Industries Additional Paid-In Capital Historical Data

The historical data trend for Greenfern Industries's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenfern Industries Additional Paid-In Capital Chart

Greenfern Industries Annual Data
Trend Mar22 Mar23
Additional Paid-In Capital
- -

Greenfern Industries Semi-Annual Data
Mar22 Mar23
Additional Paid-In Capital - -

Greenfern Industries Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Greenfern Industries Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Greenfern Industries's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenfern Industries (NZSE:GFI) Business Description

Traded in Other Exchanges
N/A
Address
115 Queen Street, Level 8, General Capital House, Auckland, NTL, NZL, 1040
Greenfern Industries Ltd is committed to the environmentally friendly production of medicinal cannabis and hemp-based products. It operates in two segments, Cannabis and therapeutics products the operations of this segment reflect the activities of manufacture and distribution of cannabis products, Electricity generation this segment includes the generation and distribution of electricity. The hemp seed and its by-products are used for a range of different products from a high protein ingredient in a plant-based meat substitute, a hemp-based skincare range, and hemp-based beverages amongst other things.